Evidence map›Paper›PMID 40985768›Full record

ArticleNucleic acids research2025

DNA polymerase kappa is the primary translesion synthesis polymerase for aldehyde ICLs.

Roxanne V van der Sluijs, Alexander E E Verkennis, Michael R Hodskinson, Jamie Barnett, Victoria M Cruz, Miguel Hernandez-Quiles, Themistoklis Liolios, Sally B Morton, Aiko Hendrikx, Collin Bos and 10 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Roxanne V van der SluijsOncode Institute, 3521 AL Utrecht, The Netherlands.
Alexander E E VerkennisOncode Institute, 3521 AL Utrecht, The Netherlands.
Michael R HodskinsonMRC Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.
Jamie BarnettOncode Institute, 3521 AL Utrecht, The Netherlands.
Victoria M CruzOncode Institute, 3521 AL Utrecht, The Netherlands.ORCID 0000-0001-5385-1472
Miguel Hernandez-QuilesOncode Institute, 3521 AL Utrecht, The Netherlands.
Themistoklis LioliosOncode Institute, 3521 AL Utrecht, The Netherlands.
Sally B MortonSheffield Institute for Nucleic Acids, School of Mathematical and Physical Sciences, University of Sheffield, Brook Hill, Sheffield S3 7HF, United Kingdom.
Aiko HendrikxOncode Institute, 3521 AL Utrecht, The Netherlands.
Collin BosOncode Institute, 3521 AL Utrecht, The Netherlands.
Harm PostBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, 3584 CH Utrecht, The Netherlands.
Christopher L MillingtonMRC Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.
Clément RouillonHubrecht Institute-KNAW and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands.
Giulia RicciHubrecht Institute-KNAW and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands.
Francesca MattiroliHubrecht Institute-KNAW and University Medical Center Utrecht, 3584 CT Utrecht, The Netherlands.ORCID 0000-0002-1574-7217
David M WilliamsSheffield Institute for Nucleic Acids, School of Mathematical and Physical Sciences, University of Sheffield, Brook Hill, Sheffield S3 7HF, United Kingdom.
Maarten AltelaarBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, 3584 CH Utrecht, The Netherlands.
Michiel VermeulenOncode Institute, 3521 AL Utrecht, The Netherlands.
K J PatelMRC Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.
Puck KnipscheerOncode Institute, 3521 AL Utrecht, The Netherlands.ORCID 0000-0003-4198-0132

Funding

European Research Council 101003210European Research Council 851564Netherlands Organization for Scientific ResearchNWOThe Dutch Cancer Society
6 · The paper itself

Abstract

DNA interstrand crosslinks (ICLs) are highly cytotoxic lesions that block essential cellular processes like replication and transcription. Endogenous ICLs can be induced by reactive aldehydes produced during normal cellular metabolism. Defective repair of these aldehyde-induced ICLs is associated with Fanconi anaemia (FA), a cancer predisposition syndrome. We previously showed that acetaldehyde-induced ICLs are repaired by the FA pathway and a novel excision-independent pathway. Here, we demonstrate that ICLs induced by acrolein, another cellular aldehyde, are also repaired by both pathways, establishing the generality of aldehyde ICL repair. Focusing on the FA pathway, we identify DNA polymerase kappa (Polκ) as the primary translesion synthesis (TLS) polymerase responsible for the insertion step during lesion bypass of unhooked aldehyde ICLs. This function requires Polκ's catalytic activity and PCNA interaction domains but is independent of Rev1 interaction. In contrast, Polκ has a non-catalytic role in the extension step of cisplatin ICL repair that is dependent on Rev1 interaction. Our work reveals a key role for Polκ in aldehyde ICL repair and provides mechanistic insights into how different ICL structures determine the choice of TLS polymerases during repair.

Indexed as

AldehydesDNA DamageDNA-Directed DNA PolymeraseDNA RepairAcroleinCisplatinFanconi AnemiaHumansNucleotidyltransferasesProliferating Cell Nuclear AntigenTranslesion DNA SynthesisY-Family DNA PolymerasesAcroleinAldehydesCisplatinDNA-Directed DNA PolymeraseNucleotidyltransferasesPOLK protein, humanProliferating Cell Nuclear AntigenREV1 protein, humanY-Family DNA Polymerases

Identifiers

PMID40985768
PMCPMC12455607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.